MedVenture Company Profile

Background

Company Name: MedVenture Partners, Inc.

Established: October 2013

Headquarters: Tokyo, Japan

Mission: To assist the commercialization of ideas based on clinical needs and vitalize the medical device ecosystem in Japan.

Vision: To create a continuous process of entrepreneurs developing startups that address clinical needs, leading to successful exits and the creation of new medical device startups.

Primary Area of Focus: Investment in seed to early-stage medical device startups.

Industry Significance: MedVenture Partners plays a pivotal role in bridging the gap between innovative medical device ideas and their successful commercialization, thereby enhancing the medical device ecosystem in Japan.

Key Strategic Focus

Core Objectives:

• Invest in startups developing medical devices that address unmet clinical needs.

• Support the rapid development and commercialization of innovative medical devices.

• Facilitate successful exits for startups, contributing to the creation of new ventures.

Specific Areas of Specialization:

• Medical devices targeting large markets with strong unmet clinical needs.

• Innovative products that present development challenges for large medical device companies.

• Startups capable of generating clinical trial data to prove efficacy and safety.

Key Technologies Utilized:

• Investment in a diverse range of medical device technologies, including minimally invasive surgical devices and catheter-based devices.

Primary Markets or Conditions Targeted:

• Medical devices addressing unmet clinical needs in Japan.

Financials and Funding

Total Funds Raised: Approximately 215.4 billion yen (approximately $1.8 billion USD).

Details of Recent Funding Rounds:

• MPI-3 Investment Limited Partnership:

• Established: February 2024

• Commitment: 9.9 billion yen

• Major Investors: Development Bank of Japan Inc., Japan Lifeline Co., Ltd., Tamron Co., Ltd., Sumitomo Bakelite Co., Ltd., Shizuoka Bank, Ltd., Innovation Network Corporation of Japan, Fukoku Mutual Life Insurance Company, among others.

• MPI-2 Investment Limited Partnership:

• Established: November 2019

• Commitment: 9.9 billion yen

• Major Investors: Development Bank of Japan Inc., Fukoku Mutual Life Insurance Company, Shizuoka Bank, Ltd., Japan Lifeline Co., Ltd., J.M.S. Co., Ltd., Tanaka Precious Metals Co., Ltd., Nihon Kohden Corporation, Zeon Medical Inc., Hamamatsu Iwata Shinkin Bank, Organization for Small & Medium Enterprises and Regional Innovation, Japan, Sekisui Chemical Co., Ltd., among others.

• MPI-1 Investment Limited Partnership:

• Established: November 2013

• Commitment: 6 billion yen

• Major Investors: Specific investor details not publicly disclosed.

Intended Utilization of Capital:

• Investing in promising medical device startups.

• Supporting product development, clinical trials, regulatory filings, and commercialization processes.

Pipeline Development

Key Pipeline Candidates:

• Investments in various medical device startups addressing unmet clinical needs in Japan.

Stages of Clinical Trials or Product Development:

• Support across all stages from seed and early stages through to late-stage investment.

Target Conditions:

• Medical devices targeting a wide range of clinical needs in Japan.

Relevant Timelines for Anticipated Milestones:

• Specific timelines for individual startups are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies:

• Investment in a diverse range of medical device technologies, including minimally invasive surgical devices and catheter-based devices.

Significant Scientific Methods:

• Utilization of extensive experience in product development, clinical trials, regulatory affairs, quality, and manufacturing to support startups.

Leadership Team

Key Executive Profiles:

• Hajime Oshita, President & CEO:

• Professional Background: Extensive experience in the medical device industry in Japan and the U.S., including investments in Fox Hollow Technologies and Chestnut Medical.

• Key Contributions: Lead investor in several successful exits, including Biomedical Solutions, Inc. and A-Traction, Inc.

• Dr. Fumiaki Ikeno, Chief Medical Officer:

• Professional Background: Over 200 startups since 2001, with experience in product development, animal testing, and clinical trials.

• Key Contributions: Guided numerous startups through successful exits, including M&A deals in Japan.

Competitor Profile

Market Insights and Dynamics:

• The medical device industry in Japan is characterized by a strong emphasis on innovation and addressing unmet clinical needs.

• There is a growing demand for venture capital to support early-stage medical device startups.

Competitor Analysis:

• MedVenture Associates:

• Focus: Investing in emerging medical technologies and devices.

• Established: 1986

• Headquarters: Emeryville, CA, USA

• Key Achievements: Identified and invested in new medical technologies and entrepreneurs developing them.

• MedVenture App:

• Focus: Connecting traveling healthcare professionals through community, resources, and tools.

• Established: February 2019

• Headquarters: Lewes, DE, USA